6th Annual Clinical Quality Oversight Forum
About This Event
An effective quality oversight strategy is critical to the success of clinical trials. Ensuring compliance and maintaining inspection readiness has become increasingly complex as risk-based approaches for quality management are being adopted, increases in outsourcing have added to the number of stakeholders involved, and quality management systems are being implemented. This results in many challenges to ensure trial integrity by effectively assessing, optimizing and management the quality of clinical vendors and sites.
At ExL's 6th Clinical Quality Oversight Forum on October 5-7 in Philly, 30 of the industry's leading experts from small, mid and large sized companies, such as Vertex, Regeneron, UCB, Shire, Pfizer, Merck, Lilly, AbbVie, Alkermes, Teva, Nektar, Alexion and many more, candidly share their experiences on what's worked and what hasn't providing practical and applicable take-away strategies to improve your operations.
Featured topics include:
Identifying Clinical Quality Metrics
Achieving Inspection Readiness
Documenting Vendor Oversight
Risk-Based Monitoring
Implementing Quality Management Systems
Optimizing Data Quality
Executing Escalation Plans and Clinical CAPAs
Risk-Based Auditing
Join your peers at this comprehensive three-day event to learn, engage and network, and leave with the knowledge and connections to ensure GCP compliance.
Time: 8:00 am - 4:00 pm
Price:
Conference and Full-Day Seminar - Before Early Bird (08/21/2015): USD 2395
Conference and Two Workshops - Before Early Bird (08/21/2015): USD 2395
Conference and One Workshop - Before Early Bird (08/21/2015): USD 2095
Conference Only - Before Early Bird (08/21/2015): USD 1795
Conference and Full-Day Seminar - Standard Pricing (after 08/21/2015): USD 2595
Conference and Two Workshops - Standard Pricing (after 08/21/2015): USD 2595
Conference and One Workshops - Standard Pricing (after 08/21/2015): USD 2295
Conference Only - Standard Pricing (after 08/21/2015): USD 1995
Speakers: David Fryrear, Darrell Morrow, Kathy Goldstein, Katie Alberta, Cheri Wilczek, Sharon Reinhard, Francois Torche, Michael Howley, Kevin Wilson, Donna Dorozinsky, Steven Talerico, Jodi Meck, Linda Sullivan, Jim Sheets, Jonathan Rowe, Kristy Nease, Maryann Livolsi, Christine Sahagian, Paul Strickland, Susan Ridge, Erika Zavod, Janice Hutt, Kathy Goin, Angela Berns, Celeste Gonzalez, Deidra Poucher, Paula Brust, AbbVie, Acceleron Pharma, Alexion R&D, Alkermes, ClinAudits, Clinical Compliance Solutions, Cluepoints, Drexel University, Eli Lilly and Company, Just in Time GCP, Merck, Metrics Champion Consortium, Nektar Therapeutics, Pfizer, Regeneron Pharmaceuticals, Shire, Strickland Quality Assurance, Sunovion Pharmaceuticals, Teva, The Avoca Group, Trevena, UCB, United Therapeutics Corporation, Vertex, Vital Therapies